IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

19.36% 21.42% 22.46% 22.75%
Piotroski F-Score
5 4 5 7
ROA
4.59% 4.79% 4.86% 4.70%
ROIC
7.07% 6.75% 6.85% 6.80%
Return on Tangible Assets
(64.02%) (87.40%) (86.94%) (67.34%)
Average Days of Receivables
76.06 76.69 74.07 72.79
Free Cash Flow per Share
13.43 12.37 13.01 13.60
Free Cash Flow
2,286.00 2,126.00 2,191.00 2,259.00
Other line items

Show all line items

Columns are period end dates